OPKO Health (NASDAQ:OPK) Rating Reiterated by Barrington Research
OPKO Health (NASDAQ:OPK – Get Free Report)‘s stock had its “outperform” rating restated by Barrington Research in a report issued on Friday, Benzinga reports. They currently have a $2.25 price target on the biotechnology company’s stock. Barrington Research’s target price indicates a potential upside of 52.03% from the company’s previous close. Several other equities analysts […]
22 Sep 07:58 · The Markets Daily